Key result
Early bariatric surgery linked to ~114% higher T2D remission odds than late surgery despite similar weight loss.
Why the study?
The study aimed to investigate the relationship between the timing of metabolic bariatric surgery and postoperative weight loss along with clinical remission of obesity-related medical conditions.
Does early metabolic bariatric surgery improve weight loss and clinical remission of obesity-related medical conditions compared to late surgery in patients with obesity?
Cohort (n=143)
No
Does early metabolic bariatric surgery improve weight loss and clinical remission of obesity-related medical conditions compared to late surgery in patients with obesity?
Odds Ratio: 2.14 (95% CI 1.31–3.56)
p-value: p=0.01
Performing metabolic bariatric surgery within 5 years of meeting obesity criteria yields superior improvements in obesity-related comorbidities and metabolic indices at 1 year compared to delayed surgery, despite similar overall weight loss.
BACKGROUND: Obesity is a global public health challenge, which is strongly associated with dozens of diseases. Metabolic bariatric surgery is recognized as a long-term and effective treatment for obesity and obesity-related medical conditions. The aim of this study is to investigate the relationship between the timing of metabolic bariatric surgery and postoperative weight loss along with the clinical remission of obesity-related medical conditions. METHODS: This study examined 143 patients with obesity who underwent laparoscopic sleeve gastrectomy (LSG) from Feb 2015 to Feb 2022. The median time from meeting the criteria for metabolic bariatric surgery to finally undergoing metabolic bariatric surgery for all participants was 5.75 years. Based on this, the participants were divided into two groups: the early operation group (persons with a duration of obesity prior to surgery of less than 5 years) and the late operation group (those with the duration of longer than 5 years). Weight metrics, biochemical indicators and improvements in obesity-related medical conditions of both groups were analyzed before the operation and 1 year after the operation. RESULTS: All patients completed a postoperative follow-up of at least 1 year. There was no significant variation in weight loss, TWL% (P ≥ 0.05) between the early operation and late operation groups. Whereas patients in the early operation group had better improvements in obesity-related medical conditions 1 year after surgery (P < 0.05). Furthermore, the early operation group showed a more pronounced decrease in related metabolic indices, such as fasting blood glucose and triglyceride (P < 0.01). CONCLUSIONS: Patients undergoing metabolic bariatric surgery experienced significant weight reduction. Notably, those in the early operation group exhibited better improvement in obesity-related medical conditions and related metabolic indices post-operation.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2025) conducted a cohort in Obesity (n=143). Early metabolic bariatric surgery vs. Late metabolic bariatric surgery was evaluated on Remission of Type 2 Diabetes Mellitus (OR 2.14, 95% CI 1.31-3.56, p=0.01). Early metabolic bariatric surgery significantly increased the likelihood of type 2 diabetes remission (OR 2.14) and improved metabolic indices compared to late surgery, despite similar weight loss.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: